The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1057
July 16, 1999
View Complete Issue         Table of Contents 2019 
Cosmetic Use of Botulinum Toxin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Cosmetic Use of Botulinum Toxin
July 16, 1999 (Issue: 1057)
Botulinum toxin type A has been marketed in the USA since 1989 for treatment of strabismus and blepharospasm and has also been used to treat cervical dystonia and some other muscular disorders.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Cosmetic Use of Botulinum Toxin
Article code: 1057a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.